52 related articles for article (PubMed ID: 1321510)
21. Comparison of the effects of carvedilol, propranolol, and verapamil on in vitro platelet function in healthy volunteers.
Gasser JA; Betterridge DJ
J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S29-34. PubMed ID: 1721976
[TBL] [Abstract][Full Text] [Related]
22. Rat platelet aggregation by ATP. Aggregometrical and ultrastructural comparison with aggregations induced by ADP and collagen.
Ts'ao C
Am J Pathol; 1976 Dec; 85(3):581-94. PubMed ID: 998732
[TBL] [Abstract][Full Text] [Related]
23. Limited usefulness of the PFA-100 for the monitoring of ADP receptor antagonists--in vitro experience.
Golanski J; Pluta J; Baraniak J; Watala C
Clin Chem Lab Med; 2004 Jan; 42(1):25-9. PubMed ID: 15061376
[TBL] [Abstract][Full Text] [Related]
24. Craviten effect on the metabolism of stored platelets.
Kotelba-Witkowska B; Stachecki B; Chmiel J; Malanowicz W; Olszewska K
Pol J Pharmacol Pharm; 1982; 34(5-6):347-56. PubMed ID: 7187049
[TBL] [Abstract][Full Text] [Related]
25. Inhibition by ADP of prostaglandin induced accumulation of cyclic AMP in intact human platelets.
Macfarlane DE; Mills DC
J Cyclic Nucleotide Res; 1981; 7(1):1-11. PubMed ID: 6265510
[TBL] [Abstract][Full Text] [Related]
26. Protective mechanisms of adenosine 5'-monophosphate in platelet activation and thrombus formation.
Fuentes E; Badimon L; Caballero J; Padró T; Vilahur G; Alarcón M; Pérez P; Palomo I
Thromb Haemost; 2014 Mar; 111(3):491-507. PubMed ID: 24306059
[TBL] [Abstract][Full Text] [Related]
27. Enzymatic removal of ADP from plasma: unaltered platelet adhesion but reduced aggregation on subendothelium and collagen fibrils.
Tschopp TB; Baumgartner HR
Thromb Haemost; 1976 Apr; 35(2):334-41. PubMed ID: 989633
[TBL] [Abstract][Full Text] [Related]
28. P2Y1-receptors in human platelets which are pharmacologically distinct from P2Y(ADP)-receptors.
Fagura MS; Dainty IA; McKay GD; Kirk IP; Humphries RG; Robertson MJ; Dougall IG; Leff P
Br J Pharmacol; 1998 May; 124(1):157-64. PubMed ID: 9630355
[TBL] [Abstract][Full Text] [Related]
29. Evidence for a role in thrombus stabilization for thromboxane A2 in human platelet deposition on collagen.
Wagner WR; Hubbell JA
J Lab Clin Med; 1992 Jun; 119(6):690-7. PubMed ID: 1534345
[TBL] [Abstract][Full Text] [Related]
30. Role of autocrine stimulation for the effects of cyclic AMP on protein and lipid phosphorylation in platelets activated by particles.
Ryningen A; Holmsen H
FEBS Lett; 1998 Oct; 436(3):335-8. PubMed ID: 9801143
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of the binding to fixed platelets of agonists and antagonists of ADP-induced aggregation.
Agarwal AK; Tandon NN; Greco NJ; Cusack NJ; Jamieson GA
Thromb Haemost; 1989 Dec; 62(4):1103-6. PubMed ID: 2617458
[TBL] [Abstract][Full Text] [Related]
32. Cyclic AMP in human blood platelets: relation to platelet prostaglandin synthesis induced by centrifugation or surface contact.
Salzman EW; Lindon JN; Rodvien R
J Cyclic Nucleotide Res; 1976; 2(1):25-37. PubMed ID: 178701
[TBL] [Abstract][Full Text] [Related]
33. Studies with human erythrocyte pyruvate kinase (PK): effects of modification of sulfhydryl groups.
Valentine WN; Paglia DE
Br J Haematol; 1983 Mar; 53(3):385-98. PubMed ID: 6824584
[TBL] [Abstract][Full Text] [Related]
34. Adrenergic regulation of Rana balcanica erythrocyte pyruvate kinase.
Kaloyianni M; Cotoglou C; Giagtzoglou N
J Comp Physiol B; 2000 Mar; 170(2):85-90. PubMed ID: 10791568
[TBL] [Abstract][Full Text] [Related]
35. ATP synthesis from ADP by the filtrate of washed rat platelet suspension through cellulose ester membrane: liberation of platelet creatine kinase.
Shibata S; Kobayashi B
Thromb Res; 1975 Sep; 7(3):417-24. PubMed ID: 1188843
[No Abstract] [Full Text] [Related]
36. Effect of ADP-utilizing enzymes on the arterial bleeding time in rats and rabbits.
Zawilska KM; Born GV; Begent NA
Br J Haematol; 1982 Feb; 50(2):317-25. PubMed ID: 7059521
[No Abstract] [Full Text] [Related]
37. Kinetics of energy consumption in human platelets with blocked ATP regeneration.
Verhoeven AJ; Mommersteeg ME; Akkerman JW
Int J Biochem; 1986; 18(11):985-90. PubMed ID: 3803700
[TBL] [Abstract][Full Text] [Related]
38. P1,P4-dithio-P2,P3-monochloromethylene diadenosine 5',5'''-P1,P4-tetraphosphate: a novel antiplatelet agent.
Chan SW; Gallo SJ; Kim BK; Guo MJ; Blackburn GM; Zamecnik PC
Proc Natl Acad Sci U S A; 1997 Apr; 94(8):4034-9. PubMed ID: 9108100
[TBL] [Abstract][Full Text] [Related]
39. The potentiation of adrenaline-induced in vitro platelet aggregation by ADP, collagen and serotonin and its inhibition by naftopidil and doxazosin in normal human subjects.
Alarayyed NA; Graham BR; Prichard BN; Smith CC
Br J Clin Pharmacol; 1995 Apr; 39(4):369-74. PubMed ID: 7640142
[TBL] [Abstract][Full Text] [Related]
40. ADP receptor antagonists and converting enzyme systems reduce platelet deposition onto collagen.
Wagner WR; Hubbell JA
Thromb Haemost; 1992 Apr; 67(4):461-7. PubMed ID: 1321510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
